// App-Quantinova.ai

3889 : An aptamer-based multiplexed proteomic technology reveals differential PKC ligand responses

Researchers

Presenter

  • Jinqiu Chen

Principal Investigators

  • Noemi Kedei

  • David J. Goldstein

  • Mariam Q. Malik

  • Peter M. Blumberg

Medical Centers

  • National Cancer Institute, Bethesda, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Alzheimer's disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • bryostatin-1

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A